NO20006243L - Protection of neurons from ischemia - Google Patents

Protection of neurons from ischemia

Info

Publication number
NO20006243L
NO20006243L NO20006243A NO20006243A NO20006243L NO 20006243 L NO20006243 L NO 20006243L NO 20006243 A NO20006243 A NO 20006243A NO 20006243 A NO20006243 A NO 20006243A NO 20006243 L NO20006243 L NO 20006243L
Authority
NO
Norway
Prior art keywords
neurons
ischemia
protection
bilobalide
stimulation
Prior art date
Application number
NO20006243A
Other languages
Norwegian (no)
Other versions
NO20006243D0 (en
Inventor
Krish Chandrasekaran
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006243D0 publication Critical patent/NO20006243D0/en
Publication of NO20006243L publication Critical patent/NO20006243L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Anvendelsen av et ekstrakt av ginkgo biloba omfattende bilobalid for å beskytte neuroner mot iskemisk skade assosiert med stimulering av mitokondriell genekspresjon, beskrives.The use of an extract of ginkgo biloba comprising bilobalide to protect neurons from ischemic damage associated with stimulation of mitochondrial gene expression is described.

NO20006243A 1998-06-11 2000-12-08 Protection of neurons from ischemia NO20006243L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9686998A 1998-06-11 1998-06-11
US8912698P 1998-06-11 1998-06-11
PCT/EP1999/004098 WO1999064028A1 (en) 1998-06-11 1999-06-10 Protecting neurons from ischemia

Publications (2)

Publication Number Publication Date
NO20006243D0 NO20006243D0 (en) 2000-12-08
NO20006243L true NO20006243L (en) 2001-02-08

Family

ID=26780277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006243A NO20006243L (en) 1998-06-11 2000-12-08 Protection of neurons from ischemia

Country Status (8)

Country Link
EP (1) EP1085886A1 (en)
JP (1) JP2002517456A (en)
KR (1) KR20010078734A (en)
AU (1) AU4772099A (en)
CA (1) CA2331918A1 (en)
IL (1) IL140196A0 (en)
NO (1) NO20006243L (en)
WO (1) WO1999064028A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
KR100623164B1 (en) * 2004-07-22 2006-09-19 재단법인서울대학교산학협력재단 Method for purifying novel ginkgo biloba extract having neuroprotective effect and composition containing same
KR100723609B1 (en) * 2006-04-28 2007-06-04 주식회사 유유 Ginkgo biloba extract for the prevention or treatment of Alzheimer's dementia and Parkinson's disease, as well as extraction and purification method from ginkgo biloba
FR2904222A1 (en) 2006-07-27 2008-02-01 Sod Conseils Rech Applic USE OF GINKGO BILOBA EXTRACTS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES
MX2009001966A (en) * 2006-08-23 2009-06-19 Univ Montana Method of reducing neuronal cell damage.
WO2012047063A2 (en) * 2010-10-08 2012-04-12 제일약품주식회사 Pharmaceutical composition for aiding dementia treatment or treating dementia, containing angelica gigas nakai extract only, ginkgo leaf extract only, or mixture of angelica gigas nakai extract and ginkgo leaf extract
CN105125897A (en) * 2015-10-05 2015-12-09 南京多宝生物科技有限公司 Extracting method and application of plant composite containing gastrodia elata
CN110893183A (en) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 Application of ginkgolide in preparation of medicine for preventing, relieving or treating amyotrophic lateral sclerosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (en) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe MEDICINAL PRODUCTS CONTAINING BILOBALID
DE3940094A1 (en) * 1989-12-04 1991-06-06 Montana Ltd ACTIVE CONCENTRATES AND NEW ACTIVE COMBINATIONS FROM BLACKERS OF GINKGO BILOBA, A METHOD FOR THE PRODUCTION THEREOF, AND THE ACTIVE CONCENTRATES THE DRUG COMBINATIONS CONTAINING DRUG COMPOUNDS
IT1238684B (en) * 1990-02-09 1993-09-01 Indena Spa BILOBALIDE DERIVATIVES, THEIR USES AND FORMULATIONS THAT CONTAIN THEM

Also Published As

Publication number Publication date
NO20006243D0 (en) 2000-12-08
IL140196A0 (en) 2002-02-10
AU4772099A (en) 1999-12-30
EP1085886A1 (en) 2001-03-28
KR20010078734A (en) 2001-08-21
JP2002517456A (en) 2002-06-18
WO1999064028A1 (en) 1999-12-16
CA2331918A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
IT7829949A0 (en) LOCK DEVICE TO AVOID UNAUTHORIZED ACCESS.
DE60022756D1 (en) SKIN CARE COMPOSITION
WO2002022611A3 (en) Caspase inhibitors and uses thereof
FI883953A0 (en) ANORDING FOR THE PURPOSE OF ORGANIZING AN ORGANIC CROPS.
NO962059L (en) Antiarrhythmic benzodiazepines
ES2164088T3 (en) ANTAGONISTS OF THE SUBSTANCE P FOR THE TREATMENT OF EMESIS.
DE50104383D1 (en) FORMULA CONTAINING BENZOFURANONE DERIVATIVES TO PROTECT AGAINST OXIDATIVE STRESS
NO20006243L (en) Protection of neurons from ischemia
FI884965L (en) VID UPPSPJAELKNING AV OXIMER HAERDANDE I K RTV-MASSOR.
DK0693278T3 (en) Combinations of vasoactive substances with fatty acids to prevent hair loss
ES2060918T3 (en) CYCLOPROPYL DERIVATIVES WHICH HAVE LIPOXIGENASE INHIBITING ACTIVITY.
DE3875866D1 (en) SULFONAMIDOLPHENYL DERIVATIVES AND THERAPEUTIC AND PREVENTIVE AGENTS AGAINST ARRHYTHMIA.
IE43618L (en) Benzimidazole derivatives
DK76788A (en) THEFT PROTECTION
BE883068A (en) BENZIMIDAZOLE DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF AND COMPOSITIONS CONTAINING THE SAME
FI885243A0 (en) OVERFLOWER PROTECTION FOR OILFINPOLYMERING.
DE3687283D1 (en) AGENT TO PROTECT THE BRAIN.
ATE108993T1 (en) LIGHT PROTECTION.
IT8619382A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF CEREBROPATHIES ON AN ORGANIC AND FUNCTIONAL BASIS.
TR200400397T4 (en) Pigment preparations improved in terms of safety
AT3862U3 (en) CRUSHING DEVICE ACCORDING TO THE PRINCIPLE OF ROTOR CRUSHING
IT8619201A0 (en) TRIAZOL DERIVATIVES AND THEIR USE TO STABILIZE ORGANIC POLYMERS.
ATE118007T1 (en) PENEM DERIVATIVES.
KR890700028A (en) Pharmaceutically active compounds and mixtures thereof, organic compositions and metal salts
SU628921A1 (en) Composition exhibiting anti-curare action, for use in experiment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application